(Q82107735)
Statements
Combination of rituximab, bortezomib, doxorubicin, dexamethasone and chlorambucil (RiPAD+C) as first-line therapy for elderly mantle cell lymphoma patients: results of a phase II trial from the GOELAMS (English)
R Houot
S Le Gouill
C Mounier
S Courby
C Dartigeas
K Bouabdallah
M Alexis Vigier
M P Moles
O Tournilhac
N Arakelyan
P Rodon
A El Yamani
L Sutton
L Fornecker
D Assouline
J L Harousseau
H Maisonneuve
S Caulet-Maugendre
French GOELAMS group